MAGNAM Trial, Magnesium Versus Amiodarone in AF in Critical Care
Condition: Atrial Fibrillation New Onset Interventions: Drug: Magnesium sulfate and then Digoxin; Drug: Amiodarone Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials
Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery
Conditions: New Onset Atrial Fibrillation; Complications; Cardiac, Postoperative Interventions: Drug: Nifekalant; Drug: Amiodarone Sponsor: Beijing Anzhen Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials